| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Debt-to-equity | 8.79 | % | +332% |
| Return On Equity | -154 | % | -121% |
| Return On Assets | -142 | % | -108% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Entity Common Stock, Shares Outstanding | 13.1M | shares | |
| Common Stock, Shares, Outstanding | 13.1M | shares | +1.71% |
| Entity Public Float | 56.6M | USD | +15% |
| Common Stock, Value, Issued | 13.1K | USD | +1.71% |
| Weighted Average Number of Shares Outstanding, Basic | 12.9M | shares | +0.46% |
| Weighted Average Number of Shares Outstanding, Diluted | 12.9M | shares | +0.46% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Research and Development Expense | 8.99M | USD | +21.7% |
| General and Administrative Expense | 1.54M | USD | -17.8% |
| Operating Income (Loss) | -10.5M | USD | -13.7% |
| Net Income (Loss) Attributable to Parent | -10.2M | USD | -15.3% |
| Earnings Per Share, Basic | -0.78 | USD/shares | -11.4% |
| Earnings Per Share, Diluted | -0.78 | USD/shares | -53.8% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Cash and Cash Equivalents, at Carrying Value | 7.22M | USD | -34% |
| Assets | 7.23M | USD | -34% |
| Employee-related Liabilities, Current | 17.8K | USD | +1543% |
| Liabilities, Current | 1.35M | USD | +349% |
| Liabilities | 1.35M | USD | +349% |
| Retained Earnings (Accumulated Deficit) | -55.4M | USD | -22.6% |
| Stockholders' Equity Attributable to Parent | 5.88M | USD | -44.8% |
| Liabilities and Equity | 7.23M | USD | -34% |
| Label | TTM Value / Value | Unit | Change % |
|---|---|---|---|
| Net Cash Provided by (Used in) Operating Activities | -1.78M | USD | -14.5% |
| Net Cash Provided by (Used in) Financing Activities | 299K | USD | |
| Common Stock, Shares Authorized | 100M | shares | 0% |
| Common Stock, Shares, Issued | 13.1M | shares | +1.71% |
| Common Stock, Par or Stated Value Per Share | 0 | USD/shares | 0% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | -1.48M | USD | +4.71% |
| Deferred Tax Assets, Valuation Allowance | 4.51M | USD | +43.6% |
| Deferred Tax Assets, Operating Loss Carryforwards | 4.51M | USD | +43.6% |
| Share-based Payment Arrangement, Expense | 4.22M | USD | +129% |